Purple Biotech Ltd. (PPBT)

CIK 1614744 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Purple Biotech Ltd..

Recent SEC filings

FiledFormAccession number
Sep 9, 20266-K0001213900-26-098378
Sep 2, 20266-K0001213900-26-096443
Aug 14, 2026SCHEDULE 13G/A0001446580-26-000101
Aug 10, 20266-K0001213900-26-087226
Aug 7, 20266-K0001213900-26-086393
Jul 29, 20266-K0001213900-26-082792
Jun 23, 20266-K0001213900-26-070884
Jun 11, 20266-K0001213900-26-067548
May 20, 2026F-30001213900-26-059665
May 15, 20266-K0001213900-26-057119
May 13, 2026SCHEDULE 13G/A0001213900-26-055837
Apr 27, 20266-K0001213900-26-047709
Apr 23, 20266-K0001213900-26-046868
Apr 17, 202630001213900-26-044999
Apr 7, 202630001213900-26-040968
Apr 6, 202630001213900-26-040511
Mar 31, 202630001213900-26-036868
Mar 30, 20263/A0001213900-26-036407
Mar 30, 202630001213900-26-036361
Mar 27, 202630001213900-26-035282
Mar 25, 20266-K0001213900-26-033843
Mar 19, 202620-F0001213900-26-031365
Mar 19, 20266-K0001213900-26-031366
Mar 18, 202630001213900-26-031048
Mar 17, 20266-K0001213900-26-028642